References
- Proc. Am. Assoc. Cancer Res. v.535 Identification of diarylsulfonylureas as novel anticancer drugs Grindey,G.B.
- Cancer Cells v.2 Currunt status of cancer drug development : faliure or limited success? Grindey,G.B.
- Cancer Res. v.51 Effect of antitumor diarylsulfonylureas on in vivo and in vitro mitochondrial structure and functions Thakar,J.H.;Chapin,C.;Houghton,P.J.
- Drug Metab. dispos v.19 Metabolism and disposition of the anticancer agent sulofenur in mouse, rat, monkey and human William,J.E.
- Drug of the future v.16 Sulofenur Howbert,J.J.
- J. Med. Chem. v.33 Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure activity relationships Grossman,C.S.;Howbert,J.J.;Crowell,T.A.;Rieder,B.J.;Harper,R.W.;Kramer,K.E.;Tao,E.V.;Aikins,J.;Poore,J.A.;Rinzel,S.M.;Grindey,G.B.;Shaw,W.H.;Todd,G.C.
- Drug of the future v.17 Discovery of novel antineoplastic sulfonylureas Border,B.B.;Ehlhardt,W.J.;Grindey,G.B.;Houghton,P.J.
- J. Chem. Soc. Perkin Trans v.1 A new synthesis of 1,2,4-benzothiadiazines and a selective preparation of o-aminobenzenesulfonamides Yves,G.;Atkinson,J.
- J. Med. Chem. v.33 Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotoxic anticancer agents which inhibit tibilin polymerization Jiang,J.B.;Hessen,D.D.;Dusak,B.A.;Dexter,D.L.;Kang,G.J.;Hamel,E.
- J. Natl. Cancer Inst. v.83 Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines Monks,A.;Scudiero,D.;Srehan,P.;Shoemaker,R.;Kenneth,P.;David,V.;Hose,C.;Langley,J.;Cronise,P.